Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Hanne Kristensen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   3.4% 2.8% 5.3% 4.6% 3.2% 3.3% 7.0% 7.0%   Credit score (0-100)   56 60 42 44 55 54 34 34   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,149 1,935 -111 -137 -347 -287 0.0 0.0   EBITDA   397 366 -595 -1,101 -1,336 -1,436 0.0 0.0   EBIT   287 259 -595 -1,101 -1,344 -1,493 0.0 0.0   Pre-tax profit (PTP)   286.0 602.6 447.5 1,086.5 882.7 1,269.8 0.0 0.0   Net earnings   222.6 472.8 346.7 845.1 685.4 988.0 0.0 0.0   Pre-tax profit without non-rec. items   286 603 447 1,086 883 1,270 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   374 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   355 628 725 1,370 1,405 1,893 1,393 1,393   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   766 946 1,161 1,820 1,825 2,390 1,393 1,393   Net Debt   -133 -114 -566 -1,012 -766 -928 -808 -808     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,149 1,935 -111 -137 -347 -287 0.0 0.0   Gross profit growth   5.9% -10.0% 0.0% -22.9% -153.5% 17.5% 0.0% 0.0%   Employees   4 3 1 0 1 1 0 0   Employee growth %   0.0% -25.0% -66.7% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   766 946 1,161 1,820 1,825 2,390 1,393 1,393   Balance sheet change%   10.7% 23.5% 22.7% 56.7% 0.3% 31.0% -41.7% 0.0%   Added value   396.6 365.6 -595.4 -1,100.9 -1,344.1 -1,436.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -64 -480 0 0 233 287 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.3% 13.4% 534.3% 803.8% 387.1% 521.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.3% 70.4% 42.7% 73.5% 58.0% 61.6% 0.0% 0.0%   ROI %   82.7% 115.3% 60.8% 98.1% 72.5% 75.3% 0.0% 0.0%   ROE %   64.8% 96.2% 51.3% 80.7% 49.4% 59.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   46.3% 66.3% 62.4% 75.2% 77.0% 79.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -33.4% -31.3% 95.1% 91.9% 57.4% 64.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.8 1.5 2.8 2.2 2.2 0.0 0.0   Current Ratio   1.0 0.8 1.5 2.8 2.2 2.2 0.0 0.0   Cash and cash equivalent   132.5 114.4 566.3 1,012.2 766.4 928.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -12.4 -58.1 199.1 -44.2 -171.3 -143.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   99 122 -595 0 -1,344 -1,436 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   99 122 -595 0 -1,336 -1,436 0 0   EBIT / employee   72 86 -595 0 -1,344 -1,493 0 0   Net earnings / employee   56 158 347 0 685 988 0 0